Benzinga · Sep 18, 2026
Argus Research Reiterates Buy on Corteva, Maintains $91 Price Target
Argus Research analyst Alexandra Yates reiterates Corteva (NYSE:CTVA) with a Buy and maintains $91 price target.

NYSE · CTVA
Basic Materials · Agricultural Inputs
$79.45
Down-$0.92 (-1.16%)
Updated Sep 25, 2026, 9:26 PM
SID Score
6.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CTVA closed at $79.45 after 20 trading sessions, down 3.58% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $81.525 | $81.525 | $79.055 | $79.45 | 3.5M |
| Sep 23, 2026 | $79.83 | $82.26 | $79.61 | $80.42 | 5.55M |
| Sep 22, 2026 | $79.07 | $81.49 | $78.59 | $80.34 | 4.09M |
| Sep 21, 2026 | $80.67 | $81.05 | $78.85 | $79.11 | 2.88M |
| Sep 18, 2026 | $80.45 | $80.97 | $80.00 | $80.53 | 7.61M |
| Sep 17, 2026 | $81.40 | $82.81 | $80.57 | $81.53 | 4.91M |
| Sep 16, 2026 | $82.58 | $83.34 | $80.70 | $81.01 | 6.48M |
| Sep 15, 2026 | $82.18 | $85.19 | $81.20 | $83.39 | 4.87M |
| Sep 14, 2026 | $84.39 | $84.79 | $82.36 | $82.54 | 4.14M |
| Sep 11, 2026 | $84.30 | $84.49 | $82.485 | $83.90 | 5.33M |
| Sep 10, 2026 | $85.04 | $86.125 | $84.21 | $84.49 | 3.59M |
| Sep 9, 2026 | $86.40 | $86.51 | $84.64 | $84.75 | 4.21M |
| Sep 8, 2026 | $88.25 | $89.13 | $84.98 | $85.90 | 4.6M |
| Sep 4, 2026 | $87.64 | $88.21 | $86.64 | $87.86 | 4.27M |
| Sep 3, 2026 | $90.24 | $90.87 | $87.96 | $88.62 | 5.55M |
| Sep 2, 2026 | $88.27 | $90.78 | $88.00 | $89.97 | 8.79M |
| Sep 1, 2026 | $85.49 | $87.84 | $85.29 | $87.73 | 5.57M |
| Aug 31, 2026 | $84.04 | $85.28 | $83.715 | $84.63 | 5.75M |
| Aug 28, 2026 | $83.18 | $84.13 | $82.06 | $83.90 | 3.13M |
| Aug 27, 2026 | $82.05 | $83.475 | $81.33 | $82.40 | 3.94M |
The latest Smart Investors Daily articles mentioning CTVA.
CTVA research
Company profile and research snapshot.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 18, 2026 | Argus Research | Buy | — |
| Sep 17, 2026 | Citigroup | Neutral | — |
| Sep 16, 2026 | RBC Capital | Outperform | — |
| Sep 16, 2026 | UBS | Neutral | — |
| Sep 16, 2026 | BMO Capital | Outperform | — |
No generated briefing is available yet.
Benzinga · Sep 18, 2026
Argus Research analyst Alexandra Yates reiterates Corteva (NYSE:CTVA) with a Buy and maintains $91 price target.
Benzinga · Sep 17, 2026
Citigroup analyst Patrick Cunningham maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $86 to $91.
SeekingAlpha · Sep 16, 2026
Corteva, Inc. (CTVA) Analyst/Investor Day September 15, 2026 9:00 AM EDTCompany ParticipantsKimberly Booth - Vice President of Investor RelationsCharles...
Benzinga · Sep 16, 2026
BMO Capital analyst Joel Jackson maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $100 to $95.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CTVA.